Qiang Yu-Ting, Wu Peng-Peng, Liu Xin, Peng Li, Zhao Li-Ke, Chen Ya-Ting, Gao Zhao-Bing, Zhao Qiang, Chen Kun
School of Pharmacy, Guizhou Medical University, Guizhou, 550025, China.
Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, 528400, China.
Acta Pharmacol Sin. 2025 Apr 2. doi: 10.1038/s41401-025-01512-y.
As important modulators of human purinergic signaling, P2X1 receptors form homotrimers to transport calcium, regulating multiple physiological processes, and are long regarded as promising therapeutic targets for male contraception and inflammation. However, the development of drugs that target the P2X1 receptor, such as the antagonist NF449, is greatly hindered by the unclear molecular mechanism of ligand binding modes and receptor activation. Here, we report the structures of the P2X1 receptor in complex with the endogenous agonist ATP or the competitive antagonist NF449. The P2X1 receptor displays distinct conformational features when bound to different types of compounds. Despite coupling to the agonist ATP, the receptor adopts a desensitized conformation that arrests the ions in the transmembrane (TM) domain, aligning with the nature of the high desensitization rates of the P2X1 receptor within the P2X family. Interestingly, the antagonist NF449 not only occupies the orthosteric pocket of ATP but also interacts with the dorsal fin, left flipper, and head domains, suggesting a unique binding mode to perform both orthosteric and allosteric mechanisms of NF449 inhibition. Intriguingly, a novel lipid binding site adjacent to the TM helices and lower body of P2X1, which is critical for receptor activation, is identified. Further functional assay results and structural alignments reveal the high conservation of this lipid binding site in P2X receptors, indicating important modulatory roles upon lipid binding. Taken together, these findings greatly increase our understanding of the ligand binding modes and multiple modulatory mechanisms of the P2X1 receptor and shed light on the further development of P2X1-selective antagonists.Keywords: Structural biology; Ligand binding mode; Ion channel; Purinergic P2X1 receptor.
作为人类嘌呤能信号的重要调节因子,P2X1受体形成同源三聚体来转运钙,调节多种生理过程,长期以来一直被视为男性避孕和炎症治疗的有前景靶点。然而,靶向P2X1受体的药物(如拮抗剂NF449)的开发因配体结合模式和受体激活的分子机制不明确而受到极大阻碍。在此,我们报道了P2X1受体与内源性激动剂ATP或竞争性拮抗剂NF449复合物的结构。当与不同类型的化合物结合时,P2X1受体呈现出不同的构象特征。尽管与激动剂ATP偶联,但受体采用脱敏构象,使离子在跨膜(TM)结构域中停滞,这与P2X1受体在P2X家族中高脱敏率的性质一致。有趣的是,拮抗剂NF449不仅占据ATP的正构口袋,还与背鳍、左鳍和头部结构域相互作用,提示其独特的结合模式可同时执行NF449抑制的正构和变构机制。有趣的是,我们鉴定出一个与P2X1的TM螺旋和下体相邻的新型脂质结合位点,该位点对受体激活至关重要。进一步的功能测定结果和结构比对揭示了该脂质结合位点在P2X受体中的高度保守性,表明脂质结合具有重要的调节作用。综上所述,这些发现极大地增进了我们对P2X1受体配体结合模式和多种调节机制的理解,并为P2X1选择性拮抗剂的进一步开发提供了线索。关键词:结构生物学;配体结合模式;离子通道;嘌呤能P2X1受体